60 Degrees Pharmaceuticals (NASDAQ:SXTP) Earns Sell (E+) Rating from Weiss Ratings
Weiss Ratings reaffirmed their sell (e+) rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Free Report) in a research report sent to investors on Wednesday,Weiss Ratings reports. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of 60 Degrees Pharmaceuticals in a report on Friday, January 10th. Check Out Our Latest Research Report on […]
Weiss Ratings reaffirmed their sell (e+) rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Free Report) in a research report sent to investors on Wednesday,Weiss Ratings reports. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of 60 Degrees Pharmaceuticals in a report on Friday, January 10th. Check Out Our Latest Research Report on […]
